← Open Payments lookup

RENEE HARRIS: Open Payments

NPI 1043350895 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,097 in 47 payments from 14 companies in 2025. Trend: 2023 $650 · 2024 $491 · 2025 $1,097

Food & beverage: $1,097
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$370
Otsuka America Pharmaceutical, Inc.14$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$160
Janssen Pharmaceuticals, Inc3$58
Teva Pharmaceuticals USA, Inc.2$50
Neurocrine BioSciences, Inc.2$45
Vanda Pharmaceuticals Inc.1$37
Noven Therapeutics, LLC2$33
Alkermes, Inc.1$31
Gilead Sciences, Inc.1$30

Products named: COBENFY, REXULTI, CAPLYTA, INVEGA SUSTENNA, INGREZZA, HETLIOZ, Xelstrym, ARISTADA.

Industry payments across MI — which companies pay providers there.